Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Work In Process (2019 - 2022)

Marimed (MRMD) has disclosed Work In Process for 4 consecutive years, with $4.1 million as the latest value for Q1 2022.

  • Quarterly Work In Process rose 857.98% to $4.1 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Mar 2022, up 857.98% year-over-year, with the annual reading at $4.7 million for FY2021, 895.14% up from the prior year.
  • Work In Process for Q1 2022 was $4.1 million at Marimed, down from $4.7 million in the prior quarter.
  • The five-year high for Work In Process was $4.7 million in Q4 2021, with the low at $80476.0 in Q4 2019.
  • Average Work In Process over 4 years is $1.9 million, with a median of $468377.0 recorded in 2020.
  • The sharpest move saw Work In Process soared 482.01% in 2020, then skyrocketed 895.14% in 2021.
  • Over 4 years, Work In Process stood at $80476.0 in 2019, then skyrocketed by 482.01% to $468377.0 in 2020, then surged by 895.14% to $4.7 million in 2021, then dropped by 12.77% to $4.1 million in 2022.
  • According to Business Quant data, Work In Process over the past three periods came in at $4.1 million, $4.7 million, and $3.4 million for Q1 2022, Q4 2021, and Q3 2021 respectively.